Contribution and Interaction of Shiga Toxin Genes to Escherichia coli O157:H7 Virulence.
Toxins (Basel). 2019 10 18; 11(10)T

Abstract

Escherichia coli O157:H7 is the predominant cause of diarrhea-associated hemolytic uremic syndrome (HUS) worldwide. Its cardinal virulence traits are Shiga toxins, which are encoded by stx genes, the most common of which are stx1a, stx2a, and stx2c. The toxins these genes encode differ in their in vitro and experimental phenotypes, but the human population-level impact of these differences is poorly understood. Using Shiga toxin-encoding bacteriophage insertion typing and real-time polymerase chain reaction, we genotyped isolates from 936 E. coli O157:H7 cases and verified HUS status via chart review. We compared the HUS risk between isolates with stx2a and those with stx2a and another gene and estimated additive interaction of the stx genes. Adjusted for age and symptoms, the HUS incidence of E. coli O157:H7 containing stx2a alone was 4.4% greater (95% confidence interval (CI) -0.3%, 9.1%) than when it occurred with stx1a. When stx1a and stx2a occur together, the risk of HUS was 27.1% lower (95% CI -87.8%, -2.3%) than would be expected if interaction were not present. At the population level, temporal or geographic shifts toward these genotypes should be monitored, and stx genotype may be an important consideration in clinically predicting HUS among E. coli O157:H7 cases.

Links

Publisher Full Text
ncbi.nlm.nih.gov
mdpi.com
PMC Free PDF

Authors+Show Affiliations

Tarr GAM
Department of Pediatrics, Cumming School of Medicine, University of Calgary, Calgary, AB T3B 6A8, Canada. gtarr@umn.edu.
Stokowski T
Department of Laboratory Medicine and Pathology, University of Alberta and Alberta Public Labs, Edmonton, AB T6G 2J2, Canada. tstokows@ualberta.ca.
Shringi S
Department of Veterinary Microbiology and Pathology, Washington State University, Pullman, WA 99163, USA. smriti_shringi@wsu.edu.
Tarr PI
Division of Gastroenterology, Hepatology, and Nutrition, Washington University School of Medicine, St. Louis, MO 63110, USA. tarr@wustl.edu.
Freedman SB
Department of Pediatrics, Cumming School of Medicine, University of Calgary, Calgary, AB T3B 6A8, Canada. stephen.freedman@ahs.ca.
Oltean HN
Washington State Department of Health, Shoreline, WA 98155, USA. hanna.oltean@doh.wa.gov.
Rabinowitz PM
Department of Environmental and Occupational Health Sciences, University of Washington, Seattle, WA 98195, USA. peterr7@uw.edu.
Chui L
Department of Laboratory Medicine and Pathology, University of Alberta and Alberta Public Labs, Edmonton, AB T6G 2J2, Canada. linda.chui@albertapubliclabs.ca.

MeSH

AdolescentAdultChildChild, PreschoolEscherichia coli InfectionsEscherichia coli O157GenotypeHemolytic-Uremic SyndromeHumansMiddle AgedRenal Replacement TherapyRiskShiga ToxinVirulenceYoung Adult

Pub Type(s)

Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

31635282